Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.
The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.
Phone: 02 9698 2022
Echelon Biosciences ionisable lipids
Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...
BioStatus CyTRAK Orange fluorescent dye
BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus...
Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent
Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies...
